These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21950469)

  • 1. Investigation of unanticipated alkylation at the N(π) position of a histidyl residue under Mitsunobu conditions and synthesis of orthogonally protected histidine analogues.
    Qian W; Liu F; Burke TR
    J Org Chem; 2011 Nov; 76(21):8885-90. PubMed ID: 21950469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells.
    Qian WJ; Park JE; Lim D; Lai CC; Kelley JA; Park SY; Lee KW; Yaffe MB; Lee KS; Burke TR
    Biopolymers; 2014 Nov; 102(6):444-55. PubMed ID: 25283071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel.
    Liu F; Park JE; Qian WJ; Lim D; Gräber M; Berg T; Yaffe MB; Lee KS; Burke TR
    Nat Chem Biol; 2011 Jul; 7(9):595-601. PubMed ID: 21765407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs.
    Qian WJ; Park JE; Lim D; Park SY; Lee KW; Yaffe MB; Lee KS; Burke TR
    Chem Biol; 2013 Oct; 20(10):1255-64. PubMed ID: 24120332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitsunobu mischief: neighbor-directed histidine N(τ)-alkylation provides access to peptides containing selectively functionalized imidazolium heterocycles.
    Qian WJ; Burke TR
    Org Biomol Chem; 2015 Apr; 13(14):4221-5. PubMed ID: 25739367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position.
    Qian W; Park JE; Liu F; Lee KS; Burke TR
    Bioorg Med Chem; 2013 Jul; 21(14):3996-4003. PubMed ID: 22743087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatase-Stable Phosphoamino Acid Mimetics That Enhance Binding Affinities with the Polo-Box Domain of Polo-like Kinase 1.
    Hymel D; Burke TR
    ChemMedChem; 2017 Feb; 12(3):202-206. PubMed ID: 27992122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1).
    Qian WJ; Park JE; Lee KS; Burke TR
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7306-8. PubMed ID: 23159568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors.
    Hymel D; Grant RA; Tsuji K; Yaffe MB; Burke TR
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3202-3205. PubMed ID: 30174151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors.
    Zhao XZ; Tsuji K; Hymel D; Burke TR
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31014020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone blocks pSer/pThr recognition by Plk1 Polo-box domain as a phosphate mimic.
    Yin Z; Song Y; Rehse PH
    ACS Chem Biol; 2013 Feb; 8(2):303-8. PubMed ID: 23135290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a new orthogonally protected glutamic acid analog and its use in the preparation of high affinity polo-like kinase 1 polo-box domain - binding peptide macrocycles.
    Hymel D; Tsuji K; Grant RA; Chingle RM; Kunciw DL; Yaffe MB; Burke TR
    Org Biomol Chem; 2021 Sep; 19(36):7843-7854. PubMed ID: 34346472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analysis of phosphopeptide binding to the polo-box domain of the mitotic kinase PLK1 using molecular dynamics simulation.
    Huggins DJ; McKenzie GJ; Robinson DD; Narváez AJ; Hardwick B; Roberts-Thomson M; Venkitaraman AR; Grant GH; Payne MC
    PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20711360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.
    Zhao XZ; Hymel D; Burke TR
    Bioorg Med Chem; 2017 Oct; 25(19):5041-5049. PubMed ID: 28285924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1.
    Ahn M; Han YH; Park JE; Kim S; Lee WC; Lee SJ; Gunasekaran P; Cheong C; Shin SY; Kim HY; Ryu EK; Murugan RN; Kim NH; Bang JK
    J Med Chem; 2015 Jan; 58(1):294-304. PubMed ID: 25347203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.
    Reindl W; Strebhardt K; Berg T
    Anal Biochem; 2008 Dec; 383(2):205-9. PubMed ID: 18793607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polo-box domain: a versatile mediator of polo-like kinase function.
    Park JE; Soung NK; Johmura Y; Kang YH; Liao C; Lee KH; Park CH; Nicklaus MC; Lee KS
    Cell Mol Life Sci; 2010 Jun; 67(12):1957-70. PubMed ID: 20148280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the binding nature of pyrrolidine pocket-dependent interactions in the polo-box domain of polo-like kinase 1.
    Murugan RN; Ahn M; Lee WC; Kim HY; Song JH; Cheong C; Hwang E; Seo JH; Shin SY; Choi SH; Park JE; Bang JK
    PLoS One; 2013; 8(11):e80043. PubMed ID: 24223211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1.
    Liu F; Park JE; Qian WJ; Lim D; Scharow A; Berg T; Yaffe MB; Lee KS; Burke TR
    Chembiochem; 2012 Jun; 13(9):1291-6. PubMed ID: 22570300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain.
    Yan F; Liu G; Chen T; Fu X; Niu MM
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31892137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.